More Information on 'Centogene AG'

CENTOGENE provides guided solutions for physicians, patients, and pharma partners, offering the world's largest genetic test portfolio for rare hereditary diseases, combining genetic and biochemical diagnostic testing to bring precision to medicine.

About Centogene AG
Centogene is a worldwide leader in the field of genetic diagnostic testing for rare hereditary diseases, with a broad test portfolio covering over 2800 genes, biochemical tests, biomarker and clinical whole exome sequencing and whole genome sequencing. Centogene’s mission is to support medical professionals with in-depth medical expertise to diagnose early and safe the reason for the patients’ burden. Analyzing samples from all over the world allows Centogene to constantly expand its unique portfolio resulting in the largest systematic documentation of the genetic results, named CentoMD®. This mutation database integrates genetic and clinical information, enabling the highest quality, knowledge-based genetic testing and biomarker development. In addition to offering diagnostic services for individual patients, Centogene is a pivotal partner to some of the most respected names in the industry.